Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1221983
Max Phase: Preclinical
Molecular Formula: C28H28ClN3OS
Molecular Weight: 490.07
Molecule Type: Small molecule
Associated Items:
ID: ALA1221983
Max Phase: Preclinical
Molecular Formula: C28H28ClN3OS
Molecular Weight: 490.07
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN[C@H]1CC[C@H](N(Cc2cccc(-c3ccncc3)c2)C(=O)c2sc3ccccc3c2Cl)CC1
Standard InChI: InChI=1S/C28H28ClN3OS/c1-30-22-9-11-23(12-10-22)32(28(33)27-26(29)24-7-2-3-8-25(24)34-27)18-19-5-4-6-21(17-19)20-13-15-31-16-14-20/h2-8,13-17,22-23,30H,9-12,18H2,1H3/t22-,23-
Standard InChI Key: VFSUUTYAEQOIMW-YHBQERECSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 490.07 | Molecular Weight (Monoisotopic): 489.1642 | AlogP: 6.79 | #Rotatable Bonds: 6 |
Polar Surface Area: 45.23 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 10.40 | CX LogP: 5.78 | CX LogD: 2.97 |
Aromatic Rings: 4 | Heavy Atoms: 34 | QED Weighted: 0.32 | Np Likeness Score: -1.60 |
1. Sinha S, Chen JK.. (2006) Purmorphamine activates the Hedgehog pathway by targeting Smoothened., 2 (1): [PMID:16408088] [10.1038/nchembio753] |
2. Heretsch P, Tzagkaroulaki L, Giannis A.. (2010) Modulators of the hedgehog signaling pathway., 18 (18): [PMID:20708941] [10.1016/j.bmc.2010.07.038] |
3. Seifert K, Büttner A, Rigol S, Eilert N, Wandel E, Giannis A.. (2012) Potent small molecule Hedgehog agonists induce VEGF expression in vitro., 20 (21): [PMID:22985958] [10.1016/j.bmc.2012.08.026] |
4. Manetti F, Petricci E, Gabrielli A, Mann A, Faure H, Gorojankina T, Brasseur L, Hoch L, Ruat M, Taddei M.. (2016) Design, synthesis and biological characterization of a new class of osteogenic (1H)-quinolone derivatives., 121 [PMID:27429255] [10.1016/j.ejmech.2016.05.062] |
5. Zhao F, Wu Y, Zhou F, Xue D, Zhao S, Lu W, Liu X, Hu T, Qiu Y, Li R, Gu T, Xu Y, Xu F, Zhong G, Jiang Z, Zhao S, Tao H.. (2021) Elucidation of Distinct Modular Assemblies of Smoothened Receptor by Bitopic Ligand Measurement., 64 (18.0): [PMID:34492176] [10.1021/acs.jmedchem.1c01220] |
Source(1):